Log in

Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and—resistant human ovarian cancer cells

  • PRECLINICAL STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

The cellular effects of a novel DNA-intercalating agent, the bipyridyl complex of platinum(II) with diphenyl thiourea, [Pt(bipy)(Ph2-tu)2]Cl2, has been analyzed in the cisplatin (cDDP)—sensitive human ovarian carcinoma cell line, 2008, and its—resistant variant, C13* cells, in which the highest accumulation and cytotoxicity was found among six related bipyridyl thiourea complexes. We also show here that this complex causes reactive oxygen species to form and inhibits topoisomerase II activity to a greater extent in the sensitive than in the resistant line. The impairment of this enzyme led to DNA damage, as shown by the comet assay. As a consequence, cell cycle distribution has also been greatly perturbed in both lines. Morphological analysis revealed deep cellular derangement with the presence of cellular masses, together with increased membrane permeability and depolarization of the mitochondrial membrane. Some of these effects, sometimes differentially evident between the two cell lines, might also be related to the decrease of total cell magnesium content caused by this thiourea complex both in sensitive and resistant cells, though the basal content of this ion was higher in the cDDP-resistant line. Altogether these results suggest that this compound exerts its cytotoxicity by mechanisms partly mediated by the resistance phenotype. In particular, cDDP-sensitive cells were affected mostly by impairing topoisomerase II activity and by increasing membrane permeability and the formation of reactive oxygen species; conversely, mitochondrial impairment appeared to play the most important role in the action of complex F in resistant cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Muggia F (2009) Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol 112:275–281

    Article  CAS  PubMed  Google Scholar 

  2. Stewart DJ (2007) Mechanisms of resistance to cisplatin and carboplatin. Critic Rev Oncol/Hematol 63:12–31

    Article  Google Scholar 

  3. Crooke ST, Duvenny VH, Galvan L, Prestayko A (1978) Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses. Mol Pharmacol 14:290–298

    CAS  PubMed  Google Scholar 

  4. Cusumano M, Di Pietro ML, Giannetto A, Vainiglia PA (2005) The intercalation to DNA of bipyridyl complexes of platinum(II) with thioureas. J Inorg Biochem 99:560–565

    Article  CAS  PubMed  Google Scholar 

  5. Marverti G, Cusumano M, Ligabue A, Di Pietro ML, Vainiglia PA, Ferrari A, Bergomi M, Moruzzi MS, Frassineti C (2008) Studies on the antiproliferative effects of novel DNA-intercalating bipiridylthiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells. J Inorg Biochem 102:699–712

    Article  CAS  PubMed  Google Scholar 

  6. Raj AS, Heddle JA (1980) Simultaneous detection of chromosomal aberrations and sister-chromatid exchanges. Mutation Res 78:253–260

    Article  CAS  PubMed  Google Scholar 

  7. Wilson WR, Harris NM, Ferguson LR (1984) Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 chinese hamster cells. Cancer Res 44:4420–4431

    CAS  PubMed  Google Scholar 

  8. Chung TDY, Drake FH, Tan KB, Per SR, Crooke ST, Mirabelli CK (1989) Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci USA 86:9431–9435

    Article  CAS  PubMed  Google Scholar 

  9. Binaschi M, Capranico G, De Isabella P, Mariani M, Supino R, Tinelli S, Zumino F (1990) Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors. Int J Cancer 45:347–352

    Article  CAS  PubMed  Google Scholar 

  10. Fukushima T, Takemura H, Yamashita T, Ishisaka T, Inai K, Imamura S, Urasaki Y, Ueda T (1999) Multidrug resistance due to impaired DNA cleavage in a VP-16-resistant human leukemia cell line. Anticancer Res 19:5111–5115

    CAS  PubMed  Google Scholar 

  11. Wolf FI, Trapani V, Cittadini A (2008) Magnesium and the control of cell proliferation: looking for a needle in a haystack. Magnesium Res 21:83–91

    CAS  Google Scholar 

  12. Covacci V, Bruzzese N, Sgambato A, Ganapathi R, Cittadini A, Wolf FI (2000) Effect of extracellular magnesium on topoisomerase II activity and expression in human leukemia HL-60 cells. J Cell Biochem 78:325–333

    Article  CAS  PubMed  Google Scholar 

  13. Rigobello MP, Folda A, Scutari G, Bindoli A (2005) The modulation of thiol redox state affects the production and metabolism of hydrogen peroxide by heart mitochondria. Arch Biochem Biophys 441:112–122

    Article  CAS  PubMed  Google Scholar 

  14. Witte AB, Anestål K, Jerremalm E, Ehrsson H, Arnér ESJ (2005) Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Free Radic Biol Med 39:696–703

    Article  CAS  PubMed  Google Scholar 

  15. Marzano C, Gandin V, Folda A, Scutari G, Bindoli A, Rigobello MP (2007) Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Free Radic Biol Med 42:872–881

    Article  CAS  PubMed  Google Scholar 

  16. Andrews PA, Albright KD (1992) Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res 52:1895–1901

    CAS  PubMed  Google Scholar 

  17. Kueng W, Siber E, Eppenberger U (1989) Quantification of cells cultured on 96-well plates. Anal Biochem 182:16–19

    Article  CAS  PubMed  Google Scholar 

  18. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65:55–63

    Article  CAS  PubMed  Google Scholar 

  19. Lugli E, Troiano L, Cossarizza A (2007) Polychromatic analysis of mitochiondrial membrane potential using JC-1. Curr Prot Cytom 7.32.1, 7.32.15

  20. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5, 5′-6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Com 197:40–45

    Article  CAS  PubMed  Google Scholar 

  21. Troiano L, Ferraresi R, Lugli E, Nemes E, Roat E, Nasi M, Pinti M, Cossarizza A (2007) Multiparametric analysis of cells with different mitochondrial membrane potential durino apoptosis by polychromatic flow cytometry. Nature Prot 2:2719–2727

    Article  CAS  Google Scholar 

  22. Marverti G, Andrews PA, Piccinini G, Ghiaroni S, Barbieri D, Moruzzi MS (1997) Modulation of cis-diamminedichloroplatinum(II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells. Eur J Cancer 33:669–675

    Article  CAS  PubMed  Google Scholar 

  23. Killilea DW, Ames BN (2008) Magnesium deficiency accelerates cellular senescence in cultured human fibroblasts. Proc Natl Acad Sci U S A 105:5768–5773

    Article  CAS  PubMed  Google Scholar 

  24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folic phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  25. Barret JM, Calsou P, Kragh Larsen A, Salles BA (1994) A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity. Mol Pharmacol 46:431–36

    CAS  PubMed  Google Scholar 

  26. Bradford MM (1976) A rapid and sensitive method for quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  27. Hutt AM, Kalf GF (1996) Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. Environ Health Perspect 104:1265–1269

    Article  CAS  PubMed  Google Scholar 

  28. Barker CR, McNamara AV, Rackstraw SA, Nelson DE, White MR, Watson AJM, Jenkins JR (2006) Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage. Nucl Acids Res 34:1148–1157

    Article  CAS  PubMed  Google Scholar 

  29. Johnson MK, Loo G (2000) Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. Mutat Res 459:211–218

    CAS  PubMed  Google Scholar 

  30. Pagliacci MC, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F, Riccardi C, Nicoletti I (1993) Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of MTT assay for evaluating cell growth and survival. Eur J Cancer 29:1573–1577

    Article  Google Scholar 

  31. Hartmann A, Speit G (1995) Genotoxic effects of chemicals in the single cell gel (SGE) test with human blood cells in relation to the induction of sister-chromatid exchanges (SCE). Mutat Res 346:49–56

    Article  CAS  PubMed  Google Scholar 

  32. Chen Y, Kramer DL, Diegelman P, Vujcic S, Porter CW (2001) Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res 61:6437–6444

    CAS  PubMed  Google Scholar 

  33. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489

    Article  CAS  PubMed  Google Scholar 

  34. Sasada T, Nakamura H, Ueda S, Sato N, Kitaoka Y, Gon Y, Takabayashi A, Spyrou G, Holmgren A, Yodoi J (1999) Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cisdiamminedichloroplatinum(II). Free Radic Biol Med 27:504–514

    Article  CAS  PubMed  Google Scholar 

  35. Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474–482

    Article  CAS  PubMed  Google Scholar 

  36. Troiano L, Granata ARM, Cossarizza A, Kalashnikova G, Bianchi R, Pini G, Tropea G, Carani C, Franceschi C (1998) Mitochondrial membrane potential and DNA stainability in human sperm cells: a flow cytometry analysis with implications for male infertilità. Exp Cell Res 241:384–393

    Article  CAS  PubMed  Google Scholar 

  37. Xu D, Lu Q, Hu X (2006) Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243:274–280

    Article  CAS  PubMed  Google Scholar 

  38. Choi W, Gerner EW, Ramdas L, Dupart J, Carew J, Proctor L, Huang P, Zhang W, Hamilton SR (2005) Combination of 5-fluorouracil and N1, N11-Diethylnorspermine markedly activates spermidine/spermine N1-acetyltransferase expression, depletes polyamines and synergistically induces apoptosis in colon carcinoma cells. J Biol Chem 280:3295–3304

    Article  CAS  PubMed  Google Scholar 

  39. Brana MF, Ramos A (2001) Naphthalimides as anticancer agents: synthesis and biological activity. Curr Med Chem-Anti-Cancer Agents 1:237–255

    Article  CAS  Google Scholar 

  40. Eder JP Jr, Chan VT-W, Ng S-W, Rizvi NA, Zacharoulis S, Teicher BA, Schnipper LE (1995) DNA topoisomerase IIα expression is associated with alkylating agent resistance. Cancer Res 55:6109–6116

    CAS  PubMed  Google Scholar 

  41. Kim T-H, Zhao Y, Barber MJ, Kuharsky DK, Yin X-M (2000) Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 275:39474–39481

    Article  CAS  PubMed  Google Scholar 

  42. Ravishankar S, Ashraf QM, Fritz K, Mishra OP, Delivoria-Papadopoulos M (2001) Expression of Bax and Bcl-2 proteins during hypoxia in cerebral cortical neuronal nuclei of newborn piglets: effect of administration of magnesium sulfate. Brain Res 901:23–29

    Article  CAS  PubMed  Google Scholar 

  43. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R (2008) Atherosclerosis and oxidative stress. Histol Histopathol 23:381–390

    CAS  PubMed  Google Scholar 

  44. Farruggia G, Iotti S, Prodi L, Montalti M, Zaccheroni N, Savage PB, Trapani V, Sale P, Wolf FI (2008) 8-Hydroxyquinoline derivatives as fluorescent sensors for magnesium in living cells. J Am Chem Soc 128:344–350

    Article  Google Scholar 

  45. Kubota T, Shindo Y, Tokuno K, Komatsu H, Ogawa H, Kudo S, Kitamura Y, Suzuki K, Oka K (2005) Mitochondria are intracellular magnesium stores: investigation by simultaneous fluorescent imagings in PC12 cells. Biochim Biophys Acta 1744:19–28

    Article  CAS  PubMed  Google Scholar 

  46. Lucy JA (1982) Biological membranes. In: Chapman D (ed) Biomembrane fusion. Academic Press, London, pp 367–415

    Google Scholar 

  47. Ahkong QF, Cramp FC, Fisher D, Howell JI, Tampion W, Verrinder M, Lucy JA (1973) Chemically-induced and thermally-induced cell fusion: lipid-lipid interactions. Nat New Biol 242:215–217

    Article  CAS  PubMed  Google Scholar 

  48. Lucy JA, Ahkong QF (1986) An osmotic model for the fusion of biological membranes. FEBS 199:1–11

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from MURST 60%, and from Associazione Angela Serra per la Ricerca sul Cancro, Azienda Ospedaliera Policlinico di Modena, Modena, Italy. This work has been also partially supported by PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) 2004, MIUR, Italy.

This work was supported by an RFO grants from the University of Bologna and PRIN 2007ZT39FN from MIUR to S. Iotti.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gaetano Marverti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marverti, G., Ligabue, A., Montanari, M. et al. Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and—resistant human ovarian cancer cells. Invest New Drugs 29, 73–86 (2011). https://doi.org/10.1007/s10637-009-9336-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-009-9336-3

Keywords

Navigation